# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066393
Filing Date
2025-05-08
Accepted
2025-05-08 07:30:23
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rapp-20250331.htm iXBRL | 10-Q | 2569669
2 | EX-10.1 | rapp-ex10_1.htm | EX-10.1 | 89130
3 | EX-31.1 | rapp-ex31_1.htm | EX-31.1 | 17550
4 | EX-31.2 | rapp-ex31_2.htm | EX-31.2 | 16934
5 | EX-32.1 | rapp-ex32_1.htm | EX-32.1 | 15889
| Complete submission text file | 0000950170-25-066393.txt |  | 9574228

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rapp-20250331.xsd | EX-101.SCH | 1267007
73 | EXTRACTED XBRL INSTANCE DOCUMENT | rapp-20250331_htm.xml | XML | 1596421

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42121 | Film No.: 25923886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)